• Fehmi TABAK
  • Mustafa ALTINDİŞ

Viral Hepat J 2017;23(1):0-0

Dear colleagues,

We are here again with the first issue of 2017 that includes interesting new subjects. This issue starts with review article titled “Current Treatment Approach in Acute Hepatitis C Infection”, and continues with the research articles titled “Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Directly Acting Antivirals”, “Distribution of Hepatitis C Virus Genotypes in the Region of ‘Istanbul Northern Anatolian Association of Public Hospitals’”, “Hepatitis B Virus and Hepatitis C Virus Co-infection: An Evaluation of 82 Patients”, “King’s Score may be More Effective in the Determination of Severe Fibrosis in Chronic Hepatitis B Infections”, “Prevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Among Cannabis and Opioid Addicts” and “Determination of Resistance Mutation in Chronic Hepatitis B Patients using antiviral drugs at our hospital”.

Apart from these, a case report titled “Elbasvir/Grazoprevir Experience-A New Glance at HCV Treatment: Case Report” and a letter to the editor titled “How to Diagnosis the Occult Hepatitis C Virus?” were included in this issue.

Our primary aim is to update the readers with the recent developments. With this purpose in mind, we expect your contributions with original articles, reviews, case reports and letters to the editor.

To meet in new issues

Prof. Dr. Fehmi TABAK, Prof. Dr. Mustafa ALTINDİŞ